tiprankstipranks
Dhampur Bio Organics Ltd (IN:DBOL)
:DBOL
India Market
Want to see IN:DBOL full AI Analyst Report?

Dhampur Bio Organics Ltd (DBOL) AI Stock Analysis

0 Followers

Top Page

IN:DBOL

Dhampur Bio Organics Ltd

(DBOL)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
₹116.00
▲(47.53% Upside)
Action:Reiterated
Date:05/31/26
The score is held back primarily by compressed profitability and inconsistent cash generation, alongside moderate leverage and much weaker ROE. Technicals add further pressure with bearish momentum (below 20/50DMA and negative MACD), despite near-oversold readings. Valuation is not especially supportive given the elevated P/E and only modest dividend yield.
Positive Factors
Integrated business model
Vertical integration across sugar milling, distillery and by-product processing supports durable operational flexibility. The ability to convert cane into sugar, ethanol and co-products reduces input-output mismatch risk, enables internal fuel use and improves margin management over multi-quarter cycles.
Negative Factors
Compressed profitability
Material margin compression reduces the earnings cushion against commodity and input cost swings and limits retained earnings for reinvestment. Persistently thin net margins make the company more sensitive to adverse price or supply shocks and constrain sustainable returns to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated business model
Vertical integration across sugar milling, distillery and by-product processing supports durable operational flexibility. The ability to convert cane into sugar, ethanol and co-products reduces input-output mismatch risk, enables internal fuel use and improves margin management over multi-quarter cycles.
Read all positive factors

Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)

Dhampur Bio Organics Ltd Business Overview & Revenue Model

Company Description
Dhampur Bio Organics Ltd., founded in 2020 and headquartered in New Delhi, India, functions as a holistic sugarcane processing enterprise. The company's operations in India involve the manufacturing and distribution of various products, such as re...
How the Company Makes Money
DBOL primarily makes money by selling (1) sugar and related sugar products and (2) ethanol produced through its distillery operations, with additional contributions from co-/by-products generated during sugarcane processing. 1) Sugar sales (core ...

Dhampur Bio Organics Ltd Financial Statement Overview

Summary
Financial statements show a modest recovery but remain uneven. Revenue rebounded in 2026 (~4.8% growth), yet profitability has materially compressed (net margin ~1.2% in 2026 vs ~4.6% in 2023; gross margin down to ~16.1% from ~25.6% in 2025). Leverage is moderate-to-elevated (debt-to-equity ~1.03) with sharply weaker ROE (~2.5% in 2026 vs ~11–12% in 2022–2023). Cash flow is the main weak spot: operating and free cash flow have been volatile despite improvement in 2026.
Income Statement
55
Neutral
Balance Sheet
58
Neutral
Cash Flow
46
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue20.12B21.09B18.62B18.39B24.08B15.54B
Gross Profit4.69B3.39B4.76B3.65B5.50B2.20B
EBITDA1.17B1.31B1.38B1.59B2.13B1.90B
Net Income-500.00K251.80M146.90M464.90M1.11B1.02B
Balance Sheet
Total Assets16.45B23.22B23.98B23.13B20.77B20.01B
Cash, Cash Equivalents and Short-Term Investments564.30M361.60M389.80M293.90M1.04B229.80M
Total Debt5.62B10.60B11.62B10.57B8.10B8.35B
Total Liabilities6.83B12.95B13.86B13.01B10.89B11.23B
Stockholders Equity9.62B10.27B10.12B10.11B9.89B8.77B
Cash Flow
Free Cash Flow6.69B1.15B-161.70M-2.72B1.45B-4.08B
Operating Cash Flow6.89B1.59B1.30B-1.01B3.55B-2.46B
Investing Cash Flow-178.20M-422.00M-1.46B-1.66B-1.96B-1.38B
Financing Cash Flow-6.52B-1.17B187.90M1.70B-781.20M3.94B

Dhampur Bio Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price78.63
Price Trends
50DMA
113.50
Negative
100DMA
108.12
Positive
200DMA
93.81
Positive
Market Momentum
MACD
0.55
Negative
RSI
47.67
Neutral
STOCH
32.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Neutral. The current price of 78.63 is below the 20-day moving average (MA) of 111.93, below the 50-day MA of 113.50, and below the 200-day MA of 93.81, indicating a neutral trend. The MACD of 0.55 indicates Negative momentum. The RSI at 47.67 is Neutral, neither overbought nor oversold. The STOCH value of 32.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:DBOL.

Dhampur Bio Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹47.60B16.191.01%15.75%4.87%
63
Neutral
₹236.80B22.5317.28%-14.67%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
₹108.00B22.901.92%9.06%9.97%
52
Neutral
₹2.98B32.420.46%-25.39%-37.39%
48
Neutral
₹7.39B29.171.63%13.31%73.17%
42
Neutral
₹746.52M88.00-11.26%-75.85%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DBOL
Dhampur Bio Organics Ltd
111.25
27.61
33.01%
IN:AWL
Adani Wilmar Limited
182.20
-76.05
-29.45%
IN:GODREJAGRO
Godrej Agrovet Limited
561.45
-210.29
-27.25%
IN:KSCL
Kaveri Seed Co. Ltd.
925.45
-247.05
-21.07%
IN:SAKUMA
Sakuma Exports Limited
1.90
-1.14
-37.50%
IN:UMAEXPORTS
Uma Exports Ltd.
22.08
-31.35
-58.67%

Dhampur Bio Organics Ltd Corporate Events

Dhampur Bio Organics Completes Rs. 305 Crore Slump Sale of Meerganj Sugar Unit
Jun 18, 2026
Dhampur Bio Organics Ltd. has completed the slump sale of its Meerganj sugar unit in Bareilly, Uttar Pradesh, transferring the business as a going concern to Forever Global Enterprises Ltd. The transaction, executed under a previously announced bu...
Dhampur Bio Organics posts stronger FY26 earnings on higher revenue base
Jun 1, 2026
Dhampur Bio Organics Ltd has published its audited consolidated financial results for the quarter and year ended 31 March 2026, showing steady top-line growth and improved profitability. Total income from operations rose to ₹781.41 crore for...
Dhampur Bio Organics Discloses Resignation of Vice President for Bottling Operations
Jun 1, 2026
Dhampur Bio Organics Ltd has announced the resignation of Mr. Rakesh Agarwal from his role as Vice President – Bottling Operations, effective at the close of business on May 31, 2026. The company stated that Agarwal tendered his resignation ...
Dhampur Bio Organics Publishes Q4 and FY26 Investor Presentation
May 30, 2026
Dhampur Bio Organics Ltd has released its investor presentation for the fourth quarter and full year ended March 31, 2026, detailing the company’s financial and operational performance. The presentation, which has been shared with stock exch...
Dhampur Bio Organics Chairman Vijay Kumar Goel Passes Away, Triggering Leadership Transition
May 10, 2026
Dhampur Bio Organics Ltd. has announced the death of its Chairman and Executive Director, Vijay Kumar Goel, who passed away on May 10, 2026, prompting formal disclosure to the BSE and NSE in line with Indian listing regulations. The board and empl...
Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd’s board has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump-sale basis to Forever Global Enterprises, signaling a strategic reshaping of its manufacturing...
Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd. has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump sale basis to Forever Global Enterprises Ltd., marking a significant portfolio reshaping of its core sugar ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 31, 2026